TCL Archive Funding Opportunities: NIH seeks “visionary thinkers” for awards of $2.5 million over five years. NCI RFA available. January 23, 2004
TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
TCL Archive DCT Board Sends Message On Cutting Grants to Extend Paylines, Then Tries To Take It Back March 2, 1984